⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2332663 | 0.78 | — | — | |
| SCHEMBL2734238 | 0.75 | — | — | |
| SCHEMBL8555332 | 0.73 | — | — | |
| SCHEMBL27786735 | 0.73 | — | — | |
| SCHEMBL1596074 | 0.71 | — | — | |
| SCHEMBL8749474 | 0.71 | — | — | |
| SCHEMBL8666161 | 0.71 | — | — | |
| SCHEMBL29216597 | 0.69 | — | — | |
| SCHEMBL27571137 | 0.68 | — | — | |
| SCHEMBL10784181 | 0.67 | TP53 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-59025373-A | — | — | None | — | — | JP | disclosed |
| CN-122070276-A | Prodrugs of xanomeline, prodrugs of trospium chloride and methods of using the same | 人类生物科学股份有限公司 | 2026-05-19 | — | — | CN | disclosed |
| US-20260124190-A1 | METHOD FOR TREATING A DISEASE OR CONDITION USING A PYRAZOLE COMPOUND OR FORMULATION THEREOF | RIGEL PHARMACEUTICALS, INC. (US) | 2026-05-07 | — | — | US | disclosed |
| EP-4705289-A1 | PRODRUGS OF XANOMELINE, PRODRUGS OF TROSPIUM AND METHODS OF USE THEREOF | Terran Biosciences Inc. (US) | 2026-03-11 | — | — | EP | disclosed |
| US-20260055110-A1 | COMPOUNDS AND METHODS FOR THE TREATMENT OF DERMAL AND OCULAR DISORDERS | AZURA OPHTHALMICS LTD (IL) | 2026-02-26 | — | — | US | disclosed |
| US-12441723-B2 | Pyrazole compounds, formulations thereof, and a method for using the compounds and/or formulations | RIGEL PHARMACEUTICALS, INC. (US) | 2025-10-14 | — | — | US | disclosed |
| US-12357623-B2 | Method for treating a disease or condition using a pyrazole compound or formulation thereof | RIGEL PHARMACEUTICALS, INC. (US) | 2025-07-15 | — | — | US | disclosed |
| US-20240382470-A1 | Irak Inhibitor for Treating Cytokine Release-Related Conditions Associated With Infection by a Respiratory Virus | RIGEL PHARMACEUTICALS INC (US) | 2024-11-21 | — | — | US | disclosed |
| WO-2024226691-A1 | PRODRUGS OF XANOMELINE, PRODRUGS OF TROSPIUM AND METHODS OF USE THEREOF | TERRAN BIOSCIENCES INC. (US) | 2024-10-31 | — | — | WO | disclosed |
| CN-118510771-A | IRAK inhibitors for the treatment of conditions associated with cytokine release associated with respiratory viral infection | 里格尔药品股份有限公司 | 2024-08-16 | — | — | CN | disclosed |
| EP-0539493-A1 | TARGETED DRUG DELIVERY VIA PHOSPHONATE DERIVATIVES. | BODOR NICHOLAS S (US) | 1993-05-05 | — | — | EP | disclosed |
| US-5177064-A | TARGETED DRUG DELIVERY VIA PHOSPHONATE DERIVATIVES | UNIVERSITY OF FLORIDA (US) | 1993-01-05 | — | — | US | disclosed |
| WO-1992017185-A1 | TARGETED DRUG DELIVERY VIA MIXED PHOSPHATE DERIVATIVES | UNIVERSITY OF FLORIDA (US) | 1992-10-15 | — | — | WO | disclosed |
| US-5100887-A | Bactericides | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-03-31 | — | — | US | disclosed |
| WO-1992000988-A1 | TARGETED DRUG DELIVERY VIA PHOSPHONATE DERIVATIVES | BODOR NICHOLAS S (US) | 1992-01-23 | — | — | WO | disclosed |
| EP-0334853-A4 | SOFT STEROIDS HAVING ANTI-INFLAMMATORY ACTIVITY. | BODOR NICHOLAS S | 1990-02-26 | — | — | EP | disclosed |
| EP-0334853-A1 | SOFT STEROIDS HAVING ANTI-INFLAMMATORY ACTIVITY | BODOR, Nicholas S. (US) | 1989-10-04 | — | — | EP | disclosed |
| WO-1989003390-A1 | SOFT STEROIDS HAVING ANTI-INFLAMMATORY ACTIVITY | BODOR NICHOLAS S (US) | 1989-04-20 | — | — | WO | disclosed |
| US-4710495-A | Soft steroids having anti-inflammatory activity | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1987-12-01 | — | — | US | disclosed |
| JP-S5925373-A | SULFONATE DERIVATIVE | KYOTO YAKUHIN KOGYO KK | 1984-02-09 | — | — | JP | disclosed |